too much regulation. No patents, no approvals, and you don't need 50k+ employees and years to find out a drug doesn't work. Under current system we wouldn't be able to approve aspirin for goodness sake. It just wouldn't go through FDA:
So says a Koch mouthpiece, at least. Your source likely isn't really interested in keeping medical care costs down - they oppose letting Medicare negotiate drug prices, push fracking, etc. It's an industry group like the AEI.
http://www.medicalprogresstoday.com/spotlight/spotlight_inda...
Haven't we had enough of high prices and stagnation in pharma already?